» Articles » PMID: 37881505

Risk Factors and Mortality of Elderly Patients with Hospital-Acquired Pneumonia of Carbapenem-Resistant Infection

Overview
Publisher Dove Medical Press
Date 2023 Oct 26
PMID 37881505
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Hospital-acquired pneumonia (HAP) caused by carbapenem-resistant (CRKP), especially in elderly patients, results in high morbidity and mortality. Studies on risk factors, mortality, and antimicrobial susceptibility of CRKP pulmonary infection among elderly patients are lacking.

Patients And Methods: A retrospective case-control study was conducted from January 2019 to December 2021. The elderly inpatients (≥65 years) who were diagnosed with HAP caused by were enrolled. Clinical data were collected. Univariate and multivariate logistic regression analyses were used to identify risk factors. Propensity score matching was used to minimize the effect of potential confounding variables. Kaplan-Meier analysis was used to compare survival.

Results: A total of 115 patients with CRKP infection and 78 patients with carbapenem-susceptible (CSKP) infection were recruited. There were four independent risk factors for CRKP infection: history of intensive care unit (ICU) stays from hospital admission to positive respiratory specimen culture for (odds ratio (OR)=2.530), Charlson comorbidity index score ≥3 (OR = 2.420), prior exposure to carbapenems (OR = 5.280), and prior infection or colonization in the preceding 3 years (OR = 18.529). The all-cause 30-day mortality was 22.3%, the mortality of CRKP and CSKP infection was 28.7% and 12.8%, respectively. Independent risk factors for mortality included: older age (OR = 1.107), immunocompromised patients (OR = 8.632), severe pneumonia (OR = 51.244), quick Sepsis-related Organ Failure Assessment (qSOFA) score ≥2 (OR = 6.187), exposure to tigecycline before infection (OR = 24.702), and prolonged ICU stay (OR = 0.987). Thirty-day mortality was significantly lower in patients receiving ceftazidime-avibactam (CAZ-AVI) containing regimens than patients receiving polymyxin B sulfate (PB) containing regimens (P = 0.048). qSOFA score had a good prognostic effect [area under receiver operating characteristic curve (AUROC) of 0.838].

Conclusion: Active screening of CRKP for the high-risk populations, especially elderly patients, is significant for early detection and successful management of CRKP infection.

Citing Articles

Comparative analysis of clinical characteristics and outcomes between carbapenem-resistant and carbapenem-sensitive infections: insights from a tertiary hospital in Northern China.

Wang B, Zhang W, Zhang H, Li M, Zhang Z, Peng X Front Med (Lausanne). 2025; 12:1499057.

PMID: 39975685 PMC: 11836024. DOI: 10.3389/fmed.2025.1499057.


Study on the predictive value of APACHE II score and neurogenic dysphagia in carbapenem-resistant Klebsiella pneumoniae.

Zhou X, Zhang Z, Wang X, Wang Y Medicine (Baltimore). 2024; 103(50):e40858.

PMID: 39686489 PMC: 11651494. DOI: 10.1097/MD.0000000000040858.


The prognostic value of neutrophil-to-lymphocyte ratio in adult carbapenem-resistant infection: a retrospective cohort study.

Wang Z, Li R, Yuan Z, Zhang Z, Qian K Front Cell Infect Microbiol. 2024; 14:1461325.

PMID: 39669277 PMC: 11634867. DOI: 10.3389/fcimb.2024.1461325.


Risk Factors and Outcomes of Community-Acquired Carbapenem-Resistant Infection in Elderly Patients.

Chen Y, Tsai I, Lai C, Lin K, Hsu Y Antibiotics (Basel). 2024; 13(3).

PMID: 38534717 PMC: 10967446. DOI: 10.3390/antibiotics13030282.


Clinical and Microbiological Risk Factors for 30-Day Mortality of Bloodstream Infections Caused by OXA-48-Producing .

Lumbreras-Iglesias P, Rodrigo-Arrazola E, Lopez-Amor L, Fernandez-Suarez J, Rodicio M, Fernandez J Pathogens. 2024; 13(1).

PMID: 38276157 PMC: 10819929. DOI: 10.3390/pathogens13010011.

References
1.
Pang F, Jia X, Zhao Q, Zhang Y . Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Ann Clin Microbiol Antimicrob. 2018; 17(1):13. PMC: 5865290. DOI: 10.1186/s12941-018-0267-8. View

2.
van Duin D, Perez F, Rudin S, Cober E, Hanrahan J, Ziegler J . Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother. 2014; 58(7):4035-41. PMC: 4068524. DOI: 10.1128/AAC.02636-14. View

3.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

4.
. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

5.
Chen Y, Chen Y, Liu P, Guo P, Wu Z, Peng Y . Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study. BMC Geriatr. 2022; 22(1):573. PMC: 9281020. DOI: 10.1186/s12877-022-03275-1. View